Veeva eConsent | End-to-End eConsent Platform

Veeva eConsent

Inform your Patients with Veeva eConsent

Deliver a better site and patient experience through an end-to-end informed consent process

Announced 2021
Status EARLY
Customers 1-10

Veeva eConsent provides a digital way to consent clinical trial participants in person or remotely.

Sponsors manage the consent forms in Vault. They can be authored in Word and digitized to include interactive elements like videos, questions, and signatures. Blinded consent data can also be viewed through the sponsors/CRO vault.

Sites are able to review and update consent documents, view participant consent status, and countersign the consents.

Participants, or other signatories consent via MyVeeva for Patients (native application or web). This is also used to access study documents and complete multiple study activities, including ePRO and visit management.

Improved patient consent process to speed clinical trials

Why Veeva ePRO

Make participation in clinical trials easier

  • Better patient experience

    Give patients direct and convenient access to their study documents on their own device.
  • Reduce site burden

    Remove administrative burden by using one eConsent system across all studies.
  • Faster study execution

    Accelerate informed consent form (ICF) creation and review by eliminating manual processes.
  • Stronger compliance

    Streamline consent monitoring and stay informed with complete visibility into consent status.


Explore and learn

Alcon and Illumina: Unifying EDC
Read article
Unifying eTMF, CTMS, and payments to accelerate clinical trials at BD
Watch video
2023 Clinical Benchmark Survey insights
View infographic
Five enterprise-wide eTMF change management techniques
Read article
Terumo's digital transformation of global clinical trial management with Vault eTMF and CTMS
Watch video
NuVasive unifies clinical operations to drive efficiency and ensure compliance
Read article

Interested in learning more about how Veeva can help?